Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Red blood cell transfusions in children awaiting heart transplantation.

Mahle WT, Berg AM, Kanter KR.

Pediatr Transplant. 2011 Nov;15(7):728-32. doi: 10.1111/j.1399-3046.2011.01561.x.

PMID:
22004547
2.

Increased red blood cell transfusions are associated with worsening outcomes in pediatric heart transplant patients.

Howard-Quijano K, Schwarzenberger JC, Scovotti JC, Alejos A, Ngo J, Gornbein J, Mahajan A.

Anesth Analg. 2013 Jun;116(6):1295-308. doi: 10.1213/ANE.0b013e31828d64ac. Epub 2013 Apr 4.

PMID:
23558832
3.

The effect of erythropoietin and blood transfusions on highly sensitized patients on a single cadaver renal allograft waiting list.

Deierhoi MH, Barger BO, Hudson SL, Shroyer TW, Diethelm AG.

Transplantation. 1992 Feb;53(2):363-8.

PMID:
1738931
4.

A controlled trial of recombinant human erythropoietin after bone marrow transplantation.

Link H, Boogaerts MA, Fauser AA, Slavin S, Reiffers J, Gorin NC, Carella AM, Mandelli F, Burdach S, Ferrant A, et al.

Blood. 1994 Nov 15;84(10):3327-35.

5.

Is a prophylactic treatment by erythropoietin relevant to reduce red blood cell transfusion in the pediatric intensive care unit?

Liet JM, Paranon S, Baraton L, Dejode JM, Rozé JC.

Pediatr Crit Care Med. 2006 Nov;7(6):541-4.

PMID:
17006380
6.

Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates.

Karpinski M, Pochinco D, Dembinski I, Laidlaw W, Zacharias J, Nickerson P.

J Am Soc Nephrol. 2004 Mar;15(3):818-24.

7.

Risk model predictive of severe anemia requiring RBC transfusion after chemotherapy in pediatric solid tumor patients.

Marec-Berard P, Blay JY, Schell M, Buclon M, Demaret C, Ray-Coquard I.

J Clin Oncol. 2003 Nov 15;21(22):4235-8.

PMID:
14615453
8.

Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.

Hensley ML, Lebeau D, Leon LF, Venkatraman E, Waltzman R, Sabbatini P, Almadrones L, Chi D, Spriggs D.

Gynecol Oncol. 2001 Jun;81(3):485-9.

PMID:
11371143
9.

Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy.

Kavanagh BD, Fischer BA 4th, Segreti EM, Wheelock JB, Boardman C, Roseff SD, Cardinale RM, Benedict SH, Goram AL.

Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):435-41.

PMID:
11567818
10.

Effect of Transfusion of Red Blood Cells With Longer vs Shorter Storage Duration on Elevated Blood Lactate Levels in Children With Severe Anemia: The TOTAL Randomized Clinical Trial.

Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, Ddungu H, Kyeyune D, Musisi E, Opoka R, Stowell CP, Dzik WH.

JAMA. 2015 Dec 15;314(23):2514-23. doi: 10.1001/jama.2015.13977.

PMID:
26637812
11.

Practice and costs of red blood cell (RBC) transfusion in an oncological unit.

Norum J, Moen MA.

Anticancer Res. 2008 Jan-Feb;28(1B):459-64.

12.

The UNOS OPTN waiting list: 1988-1995.

Harper AM, Baker AS.

Clin Transpl. 1995:69-84.

PMID:
8794255
13.

The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.

Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ.

Crit Care Med. 2004 Jan;32(1):39-52.

PMID:
14707558
14.

Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.

Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.

Pediatrics. 2003 Jun;111(6 Pt 1):e661-5.

PMID:
12777582
15.

Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor.

McPherson ME, Anderson AR, Haight AE, Jessup P, Castillejo MI, Hillyer CD, Josephson CD.

Transfusion. 2009 Sep;49(9):1977-86. doi: 10.1111/j.1537-2995.2009.02213.x. Epub 2009 May 11.

PMID:
19453984
16.

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature.

Marik PE, Corwin HL.

Crit Care Med. 2008 Sep;36(9):2667-74. doi: 10.1097/CCM.0b013e3181844677. Review. Erratum in: Crit Care Med. 2008 Nov;36(11):3134.

PMID:
18679112
17.

More clearly defining the risks of erythrocyte transfusion in the NICU.

Christensen RD, Del Vecchio A, Ilstrup SJ.

J Matern Fetal Neonatal Med. 2012 Oct;25(Suppl 5):90-2. doi: 10.3109/14767058.2012.715466. Review.

PMID:
23025778
18.

Risks, benefits, alternatives and indications of allogenic blood transfusions.

Madjdpour C, Heindl V, Spahn DR.

Minerva Anestesiol. 2006 May;72(5):283-98. Review.

19.

Anemia in the critically ill.

Shander A.

Crit Care Clin. 2004 Apr;20(2):159-78. Review.

PMID:
15135458
20.

Outcomes of children with restrictive cardiomyopathy listed for heart transplant: a multi-institutional study.

Zangwill SD, Naftel D, L'Ecuyer T, Rosenthal D, Robinson B, Kirklin JK, Stendahl G, Dipchand AI; Pediatric Heart Transplant Study Investigators.

J Heart Lung Transplant. 2009 Dec;28(12):1335-40. doi: 10.1016/j.healun.2009.06.028. Epub 2009 Sep 26.

PMID:
19783176

Supplemental Content

Support Center